What is it about?

C1-inhibitor is a serine protease inhibitor (serpin) controlling complement and contact system activation. Mutations in the SERPING1 gene result in reduced C1-inhibitor functional plasma level causing hereditary angioedema, a life-threatening disorder. Despite a stable defect, the clinical expression of hereditary angioedema is unpredictable, and the molecular mechanism underlying this variability remains undisclosed. Here we report functional and structural studies on the Arg378Cys variant found in a patient presenting reduced C1-inhibitor levels, episodically undergoing normalization.

Featured Image

Why is it important?

Our findings suggest that once correctly folded, the Arg378Cys C1-inhibitor is secreted as an active, although quite unstable, monomer. However, it could bear a folding defect, occasionally promoting protein oligomerization and interfering with the secretion process, thus accounting for its plasma level variability. This defect is exacerbated by the nature of the mutation since the acquired cysteine leads to the formation of non-functional homodimers through inter-molecular disulphide bonding. All the proposed phenomena could be modulated by specific environmental conditions, rendering this mutant exceptionally vulnerable to mild stress.

Perspectives

This observation provides with an additional argument that C1-inhibitor deficiency displays features of a serpinopathy.

Professor Christian DROUET
University Joseph Fourier Grenoble

Read the Original

This page is a summary of: Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight, Scientific Reports, January 2018, Springer Science + Business Media,
DOI: 10.1038/s41598-017-16667-w.
You can read the full text:

Read

Contributors

The following have contributed to this page